RAISING THE BAR IN BREAST CANCER CARE

Transcription

1 RAISING THE BAR IN BREAST CANCER CARE Multidisciplinary Approach in Breast Cancer October 26 th, 2018 Dan Hotel, Tel-Aviv HER2+ ER+ HER2- TNBC luminal B luminal A

2 Joseph Gligorov, MD Professor of Medicine is the Chair of Breast Cancer Expert Center, a, a Medical Practitioner and a Chief in the Department of Medical Oncology at, France. He serves as a Chair of Coordination Cancer Center at the APHP Hôpitaux Universitaires Est Parisien and Chair of Cancer School at the University Cancer Institute Pierre & Marie Curie University, Sorbonne University, Paris, France. He is a Consultant Physician at the Irva Clinic, Belgrade, Serbia. His research interest focuses on the following: clinical research in breast imaging and gynaecological oncology study of predictors of response to medical treatment, medical treatment of cancer bone metastases and improving the management of cancers. He specially focuses on Breast Cancer, including the development of new anti-cancer drugs and strategies. He is the President of the Association of Radiotherapy and Oncology of the Mediterranean area (AROME), and a member of the American Society of Clinical Oncology (ASCO), European Society for Medical Oncology (ESMO), European Society for Gynaecologic Oncology (ESGO), Société Française du Cancer (SFC) (French Cancer Society), Alliance for Cancer Research (APREC), Groupe d'etude et de Recherche en Cancreologie Onco-Radiotherapic (GERCOR) (Study and Research Group in Cancer Radiotherapy), International Bone and Mineral Society (IBMS), French National Cancer Institute (INCa), European School of Oncology (ESO), and President of the Francilian Breast Intergroup.

3 Friday, 26 th October :30-09:00 Reception 09:00-09:10 Opening Remarks 09:10-09:30 Best of ESMO in Breast Cancer 09:30-10:05 Management of Chemo and Endocrine Therapy in Premenopausal Woman with Early Breast Cancer Dr. Rinat Bernstein Molho Medical Oncologist, Medical Geneticist Breast Cancer Center, Oncology Institute Sheba Medical Center 10:05-10:45 Navigating HER2-positive ebc treatment - Raising the Bar for Cure 10:45-11:20 Optimizing Treatments in Triple Negative Breast Cancer Dr. Rotem Merose Senior Oncologist Tel-Aviv Sourasky Medical Center 09:30-11:20 Panel Discussion - Part 1 Moderator: Panel: 11:20-12:00 Coffee Break Dr. Noa Efrat Ben-Baruch Head, Israeli Breast Cancer Group Head, Department of Oncology Prof. Bella Kaufman Head, Breast Oncology Institute Sheba Medical Center Prof. Tamar Peretz-Yablonski Head, Sharett Institute of Oncology Director Center of Malignant Breast Diseases Lawrence Schacht Chair of Oncology Hadassah - Hebrew University Medical Center Prof. Rinat Yerushalmi Director, Breast Cancer Unit Davidoff Center, Rabin Medical Center Dr. Shani Paluch-Shimon Director, Breast Oncology Unit Director, the Talya Center for Young Women with Breast Cancer, Shaare Zedek Medical Center Dr. Daphna Barsuk Oncological Breast Surgeon Assuta Tel-Aviv Medical Center

4 Friday, 26 th October 2018 (continued) 12:00-12:40 Optimal Assessment and Sequencing Therapy in HER2-Positive Metastatic Breast Cancer Dr. Albert Grinshpun Oncologist Sharett Institute of Oncology Hadassah - Hebrew University Medical Center 12:40-13:15 Selection and Sequencing of Therapy for Patients with ER-Positive, HER2-Negative Metastatic Breast Cancer Dr. Ella Evron Senior Oncologist 12:00-13:15 Panel Discussion - Part 2 Moderator: Panel: Dr. Noa Efrat Ben-Baruch Head, Israeli Breast Cancer Group Head, Department of Oncology Prof. Moshe Inbar Senior Oncology Consultant Assuta Medical Centers Dr. Einav Gal-Yam Head, Ambulatory Care Unit Deputy Head, Breast Cancer Unit Institute of Oncology Sheba Medical Center, Tel Hashomer Dr. Georgeta Fried Head, Breast Cancer Oncology Unit Rambam Health Care Campus

5 PER-1809-V Roche Pharmaceuticals (Israel) Ltd. 6 Hacharash Street P.O.B Hod Hasharon Israel